| P50 | author | Roberto dell'Omo | Q42772639 |
| | Francesco Semeraro | Q56979062 |
| | Mario R. Romano | Q59691689 |
| | Ciro Costagliola | Q38327854 |
| P2093 | author name string | Giulio Bamonte | |
| | Francesco Cifariello | |
| P2860 | cites work | Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor | Q22004174 |
| | Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition | Q24313118 |
| | An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 |
| | Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 | Q24642851 |
| | High mobility group box protein-1 in experimental autoimmune uveoretinitis | Q83200155 |
| | Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy | Q83915239 |
| | Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy | Q84378690 |
| | Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes | Q84572653 |
| | Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury | Q85096646 |
| | Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy | Q95819083 |
| | HMGB1: endogenous danger signaling | Q24645232 |
| | Purtscher's retinopathy | Q24648801 |
| | The biology of VEGF and its receptors | Q27860704 |
| | Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ | Q28143727 |
| | International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 |
| | Hyperglycemia increases mitochondrial superoxide in retina and retinal cells | Q28166280 |
| | Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression | Q28192264 |
| | Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death | Q28217736 |
| | Regulation of the immune response by the interaction of chemokines and proteases | Q28237665 |
| | Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 |
| | High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 |
| | Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo | Q28243896 |
| | Glutathione | Q28261279 |
| | Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site | Q28286400 |
| | Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine | Q28505149 |
| | Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos | Q28506172 |
| | Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice | Q28508807 |
| | Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta | Q28512724 |
| | The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system | Q28567291 |
| | Intraocular expression and release of high-mobility group box 1 protein in retinal detachment | Q28574646 |
| | Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 |
| | Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 |
| | The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy | Q30845192 |
| | Multiplexed particle-based flow cytometric assays | Q30925110 |
| | Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity | Q31083347 |
| | Immunolocalization and gene expression of matrilysin during corneal wound healing | Q31934327 |
| | Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells | Q33300619 |
| | Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells | Q33450208 |
| | Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases | Q33517638 |
| | Roles of nitric oxide in brain hypoxia-ischemia | Q33631370 |
| | High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. | Q33869816 |
| | Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. | Q33944710 |
| | DNA damage and mutation in human cells exposed to nitric oxide in vitro | Q33983445 |
| | Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia | Q34011783 |
| | Early response of neurons and glial cells to hypoxia in the retina | Q46966317 |
| | Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovasc | Q47590872 |
| | Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury | Q47596744 |
| | Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. | Q47681650 |
| | Diversity of glutamate receptors in the mammalian retina | Q47833228 |
| | A New Group of Chromatin-Associated Proteins with a High Content of Acidic and Basic Amino Acids | Q47925535 |
| | Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells | Q47993319 |
| | Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia | Q48072985 |
| | ICAM-1 expression on human brain microvascular endothelial cells | Q48172123 |
| | Oxidative stress induces apoptosis in embryonic cortical neurons. | Q48226359 |
| | A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds | Q48233568 |
| | Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin | Q48269054 |
| | Cytokines in brain ischemia--the role of TNF alpha | Q48314443 |
| | Accumulation of glutamate is regulated by calcium and protein kinase C in rat hippocampal slices exposed to ischemic states | Q48315987 |
| | Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain | Q48326211 |
| | Molecular mechanisms of cell death in periventricular leukomalacia. | Q48463704 |
| | Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide | Q48464784 |
| | Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy | Q48605197 |
| | Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis | Q48609930 |
| | Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain | Q48883743 |
| | 'Ischemic tolerance' phenomenon found in the brain | Q48895274 |
| | Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons | Q48909945 |
| | Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation | Q48919234 |
| | The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features | Q67954841 |
| | N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina | Q68126319 |
| | Erythropoietin | Q68189363 |
| | Protective action of carotenoid pigments against photodynamic damage to liposomes | Q69614755 |
| | Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism | Q70139148 |
| | Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase | Q70710689 |
| | During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium | Q71472059 |
| | Surface molecules involved in the adherence of recombinant interferon-gamma (rIFN-gamma)-stimulated human monocytes to vascular endothelial cells | Q71609506 |
| | Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes [corrected] | Q71778936 |
| | Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery | Q72256441 |
| | Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat | Q72816172 |
| | Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization | Q73106062 |
| | Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells | Q73258549 |
| | AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia | Q73338130 |
| | CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation | Q73802345 |
| | AMPA Neurotoxicity in Rat Cerebellar and Hippocampal Slices: Histological Evidence for Three Mechanisms | Q74430052 |
| | The role of calcium in apoptosis | Q74589707 |
| | Structure and function of vascular endothelial growth factor receptor-1 and -2 | Q77808291 |
| | Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization | Q78785492 |
| | Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress | Q79173099 |
| | High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway | Q79828891 |
| | Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells | Q80217129 |
| | Novel role of erythropoietin in proliferative diabetic retinopathy | Q80270453 |
| | Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients | Q80350462 |
| | SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells | Q80396461 |
| | Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression | Q80459968 |
| | Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A | Q80894668 |
| | Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy | Q81473347 |
| | Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy | Q81678437 |
| | Coordinate Activation of HIF-1 and NF-κB DNA Binding and COX-2 and VEGF Expression in Retinal Cells by Hypoxia | Q40631714 |
| | Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. | Q40731011 |
| | Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine | Q40738869 |
| | SDF-1 is both necessary and sufficient to promote proliferative retinopathy. | Q40743408 |
| | Molecular basis of glutamate toxicity in retinal ganglion cells. | Q40873212 |
| | N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro | Q41133873 |
| | Bright and dark sides of nitric oxide in ischemic brain injury | Q41376372 |
| | A novel domain within the 55 kd TNF receptor signals cell death | Q41528172 |
| | Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. | Q41590787 |
| | Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate | Q41649639 |
| | Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes | Q41943468 |
| | Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor | Q42450821 |
| | H2O2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function | Q42460168 |
| | TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. | Q42477704 |
| | Glutamate induces the expression and release of tumor necrosis factor-alpha in cultured hypothalamic cells | Q42481618 |
| | Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor | Q42482076 |
| | Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease | Q42485863 |
| | Macrophages are required for cell death and tissue remodeling in the developing mouse eye. | Q42614151 |
| | The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma | Q42748164 |
| | Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. | Q42821472 |
| | Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. | Q43134760 |
| | Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. | Q43843382 |
| | Alterations in NMDA receptor expression during retinal degeneration in the RCS rat. | Q43941158 |
| | Quantitative assessment of the integrity of the blood-retinal barrier in mice | Q44046031 |
| | Nitric oxide-mediated expression of Bax protein and DNA fragmentation during hypoxia in neuronal nuclei from newborn piglets | Q44189373 |
| | Nitric oxide-mediated Ca2+/calmodulin-dependent protein kinase IV activity during hypoxia in neuronal nuclei from newborn piglets | Q44233335 |
| | Neuroretinal function during mild systemic hypoxia | Q44259876 |
| | The effects of dietary sulfur amino acid deficiency on rat brain glutathione concentration and neural damage in global hemispheric hypoxia-ischemia | Q44267497 |
| | Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells | Q44283519 |
| | Differences in nitric oxide production: a comparison of retinal ganglion cells and retinal glial cells cultured under hypoxic conditions | Q44387186 |
| | Effects of hyperoxia on microvascular cells in vitro | Q44478328 |
| | Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets | Q44687708 |
| | Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells | Q44777457 |
| | In vivo evaluation of retinal injury after transient ischemia in hypertensive rats | Q44790587 |
| | Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation | Q44804461 |
| | A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 |
| | Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. | Q45070624 |
| | Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions | Q45192916 |
| | Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. | Q45253713 |
| | Superoxide dismutase 1 protects retinal cells from oxidative damage | Q45858830 |
| | Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia | Q45871892 |
| | Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME) | Q46180826 |
| | Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology | Q46225215 |
| | Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase | Q46355086 |
| | Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy | Q46417808 |
| | Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease | Q46554065 |
| | TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells | Q46561923 |
| | Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy | Q46667958 |
| | Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. | Q46733681 |
| | Microglial activation in human diabetic retinopathy | Q46758870 |
| | Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes | Q46817516 |
| | Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats | Q46830452 |
| | Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis | Q46930334 |
| | Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. | Q50496301 |
| | Increased IL-6 levels are not related to NF-κB or HIF-1α transcription factors activity in the vitreous of proliferative diabetic retinopathy. | Q51542620 |
| | The effect of methotrexate on corneal neovascularization in rabbits. | Q51723920 |
| | Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes. | Q51756058 |
| | Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system inflammation. | Q51977677 |
| | Rat retinal ganglion cells express Ca(2+)-permeable non-NMDA glutamate receptors during the period of histogenetic cell death. | Q52225618 |
| | Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. | Q52579934 |
| | Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. | Q53243719 |
| | Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients. | Q54311414 |
| | Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. | Q54564766 |
| | Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. | Q54782207 |
| | Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. | Q55480542 |
| | C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium | Q58831549 |
| | NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones | Q59070238 |
| | Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications | Q59489258 |
| | Multiplex Bead Analysis of Vitreous Humor of Patients with Vitreoretinal Disorders | Q60207394 |
| | Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | Q62019449 |
| | The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina. | Q64996819 |
| | Microsomal Lipid Peroxidation: Morphological Characterization | Q67274599 |
| | Targeting VEGF-A to treat cancer and age-related macular degeneration | Q36628552 |
| | Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications | Q36690229 |
| | Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy | Q36751343 |
| | Vascular endothelial growth factor in eye disease | Q36929380 |
| | A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients | Q36948659 |
| | Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor | Q36983772 |
| | Advanced glycation end products (AGEs) and diabetic vascular complications | Q37065505 |
| | Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy | Q37084522 |
| | Immunological mechanisms in the pathogenesis of diabetic retinopathy | Q37109989 |
| | Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature. | Q37130174 |
| | Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). | Q37546290 |
| | Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve | Q37593617 |
| | Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling | Q37622527 |
| | The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. | Q38352705 |
| | Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. | Q39737660 |
| | Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort | Q39812990 |
| | Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy | Q39901974 |
| | Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes | Q40017265 |
| | Functional characteristics of connective tissue growth factor on vitreoretinal cells | Q40170425 |
| | Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. | Q40305741 |
| | Angiogenic factors are hematopoietic growth factors and vice versa. | Q40387055 |
| | Energy metabolism, ion homeostasis, and cell damage in the brain | Q40495278 |
| | Oxidative stress, glutamate, and neurodegenerative disorders | Q40618533 |
| | Role of connective tissue growth factor in the retinal vasculature during development and ischemia | Q34039271 |
| | Connective tissue growth factor: what's in a name? | Q34043152 |
| | Erythropoietin--an endogenous retinal survival factor | Q34164129 |
| | Nitric oxide: a novel link between synaptic and nonsynaptic transmission | Q34183621 |
| | The link between excitotoxic oligodendroglial death and demyelinating diseases | Q34183645 |
| | 4-Hydroxynonenal in the pathomechanisms of oxidative stress | Q34235488 |
| | Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 |
| | Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy | Q34324536 |
| | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo | Q34333796 |
| | Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability | Q34478521 |
| | Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? | Q34976913 |
| | HIF hydroxylation and the mammalian oxygen-sensing pathway | Q35086143 |
| | Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy | Q35102944 |
| | Advanced glycation end-products and the progress of diabetic vascular complications. | Q35717287 |
| | Historical review: Cytokines as therapeutics and targets of therapeutics | Q35737640 |
| | Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization | Q35745444 |
| | Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo | Q35747338 |
| | Ocular inflammatory effects of intravitreally-injected tumor necrosis factor | Q35818653 |
| | Dual role of tumor necrosis factor-alpha in angiogenesis | Q35830630 |
| | HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs | Q35863978 |
| | Ocular neovascularisation and excessive vascular permeability | Q35873752 |
| | Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. | Q35880995 |
| | High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. | Q35891564 |
| | Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology | Q35933719 |
| | Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy | Q35950271 |
| | Apelin signalling: a promising pathway from cloning to pharmacology. | Q35985615 |
| | Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators | Q35993096 |
| | The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions | Q36232160 |
| | Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death | Q36342647 |
| | VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. | Q36371399 |
| | The molecular action of tumor necrosis factor-alpha | Q36436880 |
| | Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients | Q36511716 |
| | Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis | Q36569348 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| | sensory nervous system | Q11101 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 935301 | |
| P577 | publication date | 2013-01-10 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Vitreous mediators in retinal hypoxic diseases | |
| P478 | volume | 2013 | |